The cash management of raised funds is not standardized, and AsiaInfo's timely financial director was given a regulatory warning by the Shanghai Stock Exchange. The Shanghai Stock Exchange announced on December 11 that it gave a regulatory warning to AsiaInfo's timely financial director Tang Xugu. After the expiration of the term of cash management of raised funds reviewed and approved by the board of directors of the company, the corresponding review and information disclosure procedures were not fulfilled in time, and the cash management of raised funds was not standardized, which violated relevant regulations.Syrian opposition forces announced the lifting of the curfew in Damascus. The Sham Liberation Organization, which currently controls the Syrian capital Damascus, issued a statement on the afternoon of the 11th local time, informing Damascus to lift the curfew and calling on local residents to return to their jobs and contribute to the construction of the city. Earlier, the organization announced that a curfew was imposed in Damascus, the capital of Syria. (CCTV News)Kaisa disclosed the progress of overseas debt restructuring. Hong Kong plans to hold a hearing on December 19, and Kaisa Group Holdings Limited issued an announcement on December 11, disclosing further information about overseas debt restructuring, involving a notice to hold a hearing. According to the announcement, Kaisa Hong Kong plans to hold a hearing in the High Court of the Hong Kong Special Administrative Region at 10 am on December 19, 2024. At the same time, Kaisa Cayman plans to hold a hearing in the Grand Court of Cayman Islands at 9: 30 am on January 15, 2025.
The institution is optimistic about these stocks today. On December 11th, as of press time, the institution gave 22 latest buy ratings, among which the target price of 8 stocks was announced:-Steady Medical was optimistic about Huatai Securities, giving a target price of 48.44 yuan; -Hongqi Chain was favored by CITIC Securities, with a target price of 6.80 yuan; -Contemporary Amperex Technology Co., Limited, Jinshiyuan, Fulongma and many other stocks are listed.The institution is optimistic about these stocks today. On December 11th, as of press time, the institution gave 22 latest buy ratings, among which the target price of 8 stocks was announced:-Steady Medical was optimistic about Huatai Securities, giving a target price of 48.44 yuan; -Hongqi Chain was favored by CITIC Securities, with a target price of 6.80 yuan; -Contemporary Amperex Technology Co., Limited, Jinshiyuan, Fulongma and many other stocks are listed.German Chancellor Scholz: Decisions need to be made before the end of the year, such as improving children's welfare. It is necessary to solve the financial drag problem before the end of the year.
ExxonMobil Oil: US President-elect Trump will bring good prospects to the US oil and gas industry. Support US President-elect Trump to repair the "broken" licensing system in the US energy field.The UN Secretary-General visited South Africa and called on the G20 to reform global financial institutions. On December 11th, local time, UN Secretary-General Guterres visited South Africa and attended the first meeting of G20 finance ministers and central bank governors in Johannesburg after South Africa assumed the rotating presidency of G20. Guterres called on the G20 to achieve financial justice, reform global financial institutions and expand the global safety net. He also expressed support for South Africa as the rotating presidency of G20. In the afternoon, Guterres met with South African Foreign Minister Lamora in the South African Foreign Ministry Building. The two sides discussed the priorities of the G20 presidency, promoted the implementation of future agreements, and ensured the accelerated realization of sustainable development and climate commitments. (CCTV News)Macy's fell 8.2% before the market, and the company lowered its profit outlook after discovering accounting errors.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14